Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Medivation Inc    

SummaryNewsCompany 
News SummaryMost relevantAll newsSector newsTweets 

Medivation Inc : Medivation Announces Participation at Upcoming Investor Conferences

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/30/2013 | 10:34pm CEST

SAN FRANCISCO, CA -- (Marketwired) -- 10/28/13 -- Medivation, Inc. (NASDAQ: MDVN) today announced that it will host a live teleconference with management to discuss third quarter 2013 financial results and provide a general business update on November 12, 2013 at 4:30 p.m. Eastern Time. A press release for the third quarter of 2013 will be released after markets close on November 12, 2013.

Interested parties may listen to the live teleconference by calling 877-303-2523 from the U.S. or +1-253-237-1755 internationally. Individuals may access the live audio webcast by visiting: http://investors.medivation.com/events.cfm.

About Medivation
Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families. For more information, please visit us at www.medivation.com.

Contacts:
Patrick Machado
Chief Business & Financial Officer
(415) 829-4101

Anne Bowdidge
Sr. Director, Investor Relations
(650) 218-6900

Source: Medivation

News Provided by Acquire Media

distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on MEDIVATION INC
2016 Drugmaker Sanofi hungry for deals after earnings beat
2016 MEDIVATION : New Data Presented at ESMO 2016 Further Demonstrates XTANDITM▼..
2016 PFIZER : Completes Acquisition of Medivation
2016 MEDIVATION, INC. : Termination of a Material Definitive Agreement, Completion of..
2016 PFIZER INC. (NYSE : PFE) Acquisition Of Medivation, Inc. (NASDAQ:MDVN) To Close ..
2016 Xenon Pharmaceuticals Appoints Dawn Svoronos to Its Board of Directors
2016 MEDIVATION : Highlights New Data From Differentiated Oncology Portfolio at ESMO ..
2016 PFIZER : Announces Expiration of HSR Waiting Period For Proposed Acquisition of ..
2016DJPfizer Throws Out Plan to Split Into Two Companies
2016 PFIZER : expects to close Medivation buyout in 3Q
More news
Sector news : Bio Therapeutic Drugs
06/23DJOne of the Last Untapped Blockbuster Diseases? Drug Companies Race to Find a ..
06/20 Novartis eye drug works with fewer injections than rival
06/15DJACTELION : J&J Maps Research Plans for Actelion -- WSJ
06/14DJACTELION : Correction to J&J Actelion Story
06/14DJACTELION : J&J Plans to Add Drug Discovery and Early Research to Actelion Unit
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
05/17 Vantage Point - Are Charities The Best Way To Pay For Costly Drugs?
04/10 Axovant Sciences announces appointment of Dr. David Hung as CEO and expansion..
03/06 BIOTECH FORUM DAILY DIGEST : Biotech Closes Above Resistance Levels. Icahn Getti..
02/10 BIOTECH FORUM DAILY DIGEST : Buyout Rumors On The Rise; Aratana Therapeutics' De..
02/03 Pfizer May Be Another IBM
Advertisement
Managers
NameTitle
David T. Hung President, Chief Executive Officer & Director
Kim D. Blickenstaff Chairman
Mohammad Hirmand Chief Medical Officer
Anne Bowdidge Senior Director-Investor Relations
Sandy Cooper Senior Vice President-Human Resources
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
MEDIVATION INC0
AMGEN16.85%125 643
CELGENE CORPORATION13.05%102 171
GILEAD SCIENCES-1.34%92 320
REGENERON PHARMACEUTIC..40.54%53 371
VERTEX PHARMACEUTICALS75.42%32 187
More Results